Skip to main content
Premium Trial:

Request an Annual Quote

Bayer, Precision BioSciences in Crop Genome Modification Alliance

NEW YORK (GenomeWeb News) – Bayer CropScience, the agricultural subsidiary of Bayer, and Precision BioSciences announced today that they will collaborate on creating site-specific genome modifications in plants.

Under the deal, Bayer will have non-exclusive access to Precision Bio's Direct Nuclease Editor technology, which can be used to develop novel traits in plants, the firms said. Precision Bio also will supply Bayer with multiple DNE-engineered enzymes for use across the company's crop platforms.

The DNE technology utilizes protein engineering methods to produce rationally designed, obligate heterodimer endonucleases that have the ability to modify single, unique sites within a large genome. According to the partners, crop researchers can use the technology to insert multiple genes at a single site within a plant chromosome, thereby efficiently and precisely conferring desirable traits into plant species.

Financial and other terms of the alliance were not disclosed.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.